Kimberly-Clark Corporation is an American multinational personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
| Revenue (TTM) | $16.58B |
| Gross Profit (TTM) | $6.24B |
| EBITDA | $3.48B |
| Operating Margin | 19.00% |
| Return on Equity | 104.90% |
| Return on Assets | 10.20% |
| Revenue/Share (TTM) | $49.95 |
| Book Value | $5.26 |
| Price-to-Book | 18.80 |
| Price-to-Sales (TTM) | 1.97 |
| EV/Revenue | 2.319 |
| EV/EBITDA | 12.02 |
| Quarterly Earnings Growth (YoY) | -32.30% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $332.58M |
| Float | $331.31M |
| % Insiders | 0.71% |
| % Institutions | 99.25% |
Volatility is currently contracting
Kimberly-Clark just logged 54 straight years of dividend raises, but a closer look at the cash flow statement raises an uncomfortable question about who is actually funding that growing payout.
Kimberly-Clark has offered concessions to address EU antitrust concerns about its $40 billion bid for Tylenol maker Kenvue , a filing on the European Commission website showed on Wednesday.
While investors pile into pricey AI darlings, a handful of battle-tested Dividend Kings have quietly slipped to levels that scream value, and Wall Street analysts see serious upside ahead for 2027.
Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not be sustainable.
KMB is tackling $150 million of second-half input-cost pressure with targeted pricing, productivity gains and supplier actions.
KMB's North America business faces near-term shipment pressure, but innovation, share gains and easier comparisons support a stronger second half.
KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, debt and legal risks temper the Q4 2026 outlook.
Huggies renames its nano and micro preemie diapers "Huggies Little Fighters" and marks NICU Awareness Month by spotlighting real stories and supporting families CHICAGO, Sept. 3, 2026 /PRNewswire/ -- This NICU Awareness Month, Huggies® is rallying families, caregivers and communities to recognize the extraordinary strength of babies in the NICU, and the people fighting alongside them.
Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeover of Kenvue , on condition the company divests Kenvue's Carefree and Stayfree period care brands in the country to address competition concerns.
DALLAS, Sept. 1, 2026 /PRNewswire/ -- Mike Hsu, Chairman and CEO of Kimberly-Clark Corporation (NASDAQ: KMB), Russ Torres, President and Chief Operating Officer, and Nelson Urdaneta, Chief Financial Officer, will be featured speakers at the Barclays 19th Annual Global Consumer Staples Conference on Wednesday, September 9, at 7:30 a.m.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KMB and any ticker you trade — then tracks every position and per-strategy win rate.
